Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 125.72%13.47M | -41.85%36.71M | 17.36M | -33.53%6.2M | -75.65%4.38M | 63.14M | -45.94%5.97M | -69.81%11.04M | 9.33M | 17.99M |
| Cost of revenue | 74.75%11.07M | -40.29%34.94M | 16.49M | -18.48%6.02M | -68.10%4.24M | 58.51M | -16.15%6.34M | -75.84%7.56M | 7.39M | 13.28M |
| Gross profit | 754.22%2.4M | -61.57%1.78M | 866K | -90.69%181K | -96.92%145K | 4.63M | -110.53%-367K | -34.31%3.49M | 1.95M | 4.71M |
| Operating expense | -27.92%2.76M | -55.80%8.77M | 2.2M | -32.70%2.45M | -23.39%2.16M | 19.84M | -14.55%3.83M | 20.01%4.48M | 3.65M | 2.82M |
| Selling and administrative expenses | -27.92%2.76M | -55.80%8.77M | --2.2M | -32.70%2.45M | -20.83%2.23M | --19.84M | -14.55%3.83M | 55.86%4.48M | --3.65M | --2.82M |
| -Selling and marketing expense | 143.33%146K | -55.70%276K | --75K | 48.03%225K | ---- | --623K | -47.37%60K | -12.98%114K | --152K | --141K |
| -General and administrative expense | -30.64%2.61M | -55.81%8.49M | --2.13M | -36.22%2.23M | -16.66%2.23M | --19.22M | -13.69%3.77M | 59.15%4.37M | --3.49M | --2.68M |
| Total other operating income | ---- | ---- | ---- | ---- | --72K | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 91.44%-359K | 54.05%-6.99M | -1.34M | -33.65%-2.27M | -206.39%-2.01M | -15.21M | -321.71%-4.2M | -163.25%-995K | -1.7M | 1.89M |
| Net non-operating interest income (expenses) | -1,290.48%-292K | -122.53%-960K | -269K | -1,005.00%-221K | -1,582.61%-387K | -431.41K | 8.70%-21K | 11.54%-23K | -20K | -23K |
| Non-operating interest expense | 1,290.48%292K | 122.53%960K | --269K | 1,005.00%221K | 1,582.61%387K | --431.41K | -8.70%21K | -11.54%23K | --20K | --23K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 100.86%333K | 0 | 0 | 333K | -38.68M | 0 | 0 | ||
| Less:Write off | --0 | -100.86%-333K | --0 | --0 | ---333K | --38.68M | ---- | --0 | --0 | ---- |
| Other non-operating income (expenses) | 68.55%-39K | 104.68%159K | 202K | -785.71%-62K | 67.03%-90K | -3.4M | -110.56%-124K | 138.62%1.17M | -7K | -273K |
| Income before tax | 84.11%-690K | 87.08%-7.46M | -1.4M | -47.94%-2.56M | -235.13%-2.16M | -57.72M | -2,882.69%-4.34M | -92.35%156K | -1.73M | 1.6M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 412.32K | 160.00%3K | -100.83%-5K | -243K | 209K |
| Net income | 84.12%-690K | 87.17%-7.46M | -1.4M | -72.17%-2.56M | -255.48%-2.16M | -58.14M | -2,798.14%-4.34M | -88.80%161K | -1.48M | 1.39M |
| Net income continuous operations | 84.12%-690K | 87.17%-7.46M | ---1.4M | -72.17%-2.56M | -255.48%-2.16M | ---58.14M | -2,798.14%-4.34M | -88.80%161K | ---1.48M | --1.39M |
| Noncontrolling interests | -100.00%-30K | 26.68%-66K | -30K | -1,000.00%-27K | 153.85%14K | -90.02K | 46.43%-15K | 0.00%-28K | 3K | -26K |
| Net income attributable to the company | 84.75%-660K | 87.27%-7.39M | -1.37M | -70.01%-2.53M | -253.61%-2.17M | -58.05M | -2,390.48%-4.33M | -87.10%189K | -1.49M | 1.41M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 84.75%-660K | 87.27%-7.39M | -1.37M | -70.01%-2.53M | -253.61%-2.17M | -58.05M | -2,390.48%-4.33M | -87.10%189K | -1.49M | 1.41M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 85.44%-0.0015 | 88.05%-0.0167 | -0.0031 | -58.33%-0.0057 | -240.00%-0.0049 | -0.1397 | -2,160.00%-0.0103 | -86.49%0.0005 | -0.0036 | 0.0035 |
| Diluted earnings per share | 85.44%-0.0015 | 88.05%-0.0167 | -0.0031 | -58.33%-0.0057 | -1,080.00%-0.0049 | -0.1397 | -10,400.00%-0.0103 | -80.00%0.0001 | -0.0036 | 0.0005 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.